Extendicare (TSE:EXE – Get Free Report) received a C$15.40 price target from National Bankshares in a research report issued to clients and investors on Thursday,BayStreet.CA reports. The brokerage currently has an “outperform” rating on the stock. National Bankshares’ price target would suggest a potential upside of 19.29% from the stock’s current price.
A number of other equities research analysts have also weighed in on EXE. BMO Capital Markets lifted their price objective on shares of Extendicare from C$13.50 to C$14.50 in a report on Monday, May 12th. TD Securities lifted their price target on Extendicare from C$13.00 to C$15.00 and gave the company a “hold” rating in a report on Thursday, May 22nd. Three research analysts have rated the stock with a hold rating, one has assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, Extendicare presently has a consensus rating of “Moderate Buy” and an average price target of C$13.98.
Extendicare Trading Down 2.4%
Extendicare Company Profile
Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.
Further Reading
- Five stocks we like better than Extendicare
- Upcoming IPO Stock Lockup Period, Explained
- Why Pure Storage Is a Core Investment for the AI Era
- Following Congress Stock Trades
- 2025: A Pivotal Year for Smart Glasses As Meta Invests in Ray-Ban
- How to Invest in the Best Canadian Stocks
- Unity’s New Ad Solutions Drive Stock to 52-Week High
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.